Header Logo

Connection

Steven Feinstein to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Steven Feinstein has written about Cost-Benefit Analysis.
Steven Feinstein
Connection Strength
0.009
Cost-Benefit Analysis
  1. Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison Multicenter Study Group. Am J Manag Care. 1998 Sep 25; 4 Spec No:SP169-76.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.